{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:48:48Z","timestamp":1769226528333,"version":"3.49.0"},"reference-count":120,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"funded by Pfizer Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/14760584.2023.2245467","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:09:31Z","timestamp":1695888571000},"page":"839-848","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease"],"prefix":"10.1080","volume":"22","author":[{"given":"Cynthia","family":"Burman","sequence":"first","affiliation":[{"name":"Vaccines, Antivirals and Evidence Generation, Pfizer Inc, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[{"name":"Vaccines, Antivirals and Evidence Generation, Pfizer Ltd, Tadworth, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S.","family":"Marshall","sequence":"additional","affiliation":[{"name":"The Women\u2019s and Children\u2019s Hospital and Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-9446","authenticated-orcid":false,"given":"Marco A.P.","family":"Safadi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Santa Casa de S\u00e3o Paulo School of Medical Sciences, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6909a1"},{"key":"e_1_3_6_3_1","first-page":"1","volume-title":"StatPearls","author":"Siddiqui JA","year":"2022","unstructured":"Siddiqui JA, Ameer MA, Gulick PG. Meningococcemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. p. 1\u20137."},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103571"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1557520"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2130"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1790"},{"key":"e_1_3_6_9_1","volume-title":"Menactra (meningococcal [groups A, C, Y, and W-135] polysaccharide diphtheria toxoid conjugate vaccine solution for intramuscular injection)","year":"2019","unstructured":"Menactra (meningococcal [groups A, C, Y, and W-135] polysaccharide diphtheria toxoid conjugate vaccine solution for intramuscular injection). Full Prescribing Information. Swiftwater PA: 2019."},{"key":"e_1_3_6_10_1","volume-title":"Menveo (meningococcal [groups A, C, Y, and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine)","year":"2022","unstructured":"Menveo (meningococcal [groups A, C, Y, and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine). Full Prescribing Information. Durham NC: GlaxoSmithKline; 2022."},{"key":"e_1_3_6_11_1","volume-title":"Summary of Product Characteristics","author":"Nimenrix (meningococcal [groups A, C, W-135, and Y] conjugate vaccine)","year":"2017","unstructured":"Nimenrix (meningococcal [groups A, C, W-135, and Y] conjugate vaccine). Summary of Product Characteristics. Bruxelles, Belgium: Pfizer Europe; 2017."},{"key":"e_1_3_6_12_1","volume-title":"MenQuadfi (meningococcal [groups A, C, Y, and W] conjugate vaccine)","year":"2022","unstructured":"MenQuadfi (meningococcal [groups A, C, Y, and W] conjugate vaccine). Full Prescribing Information. Swiftwater PA: Sanofi Pasteur Inc; 2022."},{"key":"e_1_3_6_13_1","volume-title":"Summary of Product Characteristics","author":"Meningococcal A conjugate vaccine (MenAfriVac)","year":"2023","unstructured":"Meningococcal A conjugate vaccine (MenAfriVac). Summary of Product Characteristics. Hadapsar Pune: Serum Institute of India Pvt Ltd; 2023."},{"key":"e_1_3_6_14_1","volume-title":"Menjugate liquid (10 microgram suspension for injection; meningococcal group C conjugate vaccine)","year":"2021","unstructured":"Menjugate liquid (10 microgram suspension for injection; meningococcal group C conjugate vaccine). Siena, Italy: Summary of Product Characteristics. GlaxoSmithKline Inc; 2021."},{"key":"e_1_3_6_15_1","volume-title":"Summary of Product Characteristics","author":"Package leaflet: NeisVac-C vaccine","year":"2022","unstructured":"Package leaflet: NeisVac-C vaccine. Summary of Product Characteristics. Dublin Ireland: Pfizer Healthcare Ireland; 2022."},{"key":"e_1_3_6_16_1","volume-title":"Summary of Product Characteristics","author":"Menitorix powder and solvent for solution for injection","year":"2020","unstructured":"Menitorix powder and solvent for solution for injection. Summary of Product Characteristics. Brentford, Middlesex: GlaxoSmithKline UK; 2020."},{"key":"e_1_3_6_17_1","volume-title":"Trumenba (meningococcal group B vaccine suspension for intramuscular injection)","year":"2021","unstructured":"Trumenba (meningococcal group B vaccine suspension for intramuscular injection). Full Prescribing Information. Philadelphia PA: Pfizer Inc; 2021."},{"key":"e_1_3_6_18_1","volume-title":"Full Prescribing Information","year":"2022","unstructured":"Bexsero (Meningococcal group B vaccine suspension for intramuscular injection). Full Prescribing Information. Research Triangle Park, NC: GlaxoSmithKline; 2022."},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix993"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12933-3"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.01340"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.024"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.28.30574"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2019.10.003"},{"key":"e_1_3_6_26_1","first-page":"65","article-title":"Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60:65\u201368.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_6_27_1","unstructured":"Centers for Disease Control and Prevention. Taking complement inhibitors increases your risk for meningococcal disease [Internet]. [cited 2023 Sep 7]; https:\/\/www.cdc.gov\/meningococcal\/about\/soliris-patients.html"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix438"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6738a4"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0196-z"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1849518"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1528831"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-2016-000695"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6627e1"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.04.056"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.332-337.2004"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181c38f3b"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.069"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000630"},{"key":"e_1_3_6_41_1","unstructured":"Australian Government Department of Health and Aged Care. Meningococcal vaccination for people in a special risk group [Internet]. [cited 2023 Sep 7]; https:\/\/immunisationhandbook.health.gov.au\/sites\/default\/files\/2023-03\/AIH-Meningococcal-Other-07%2822Mar23%29.pdf"},{"key":"e_1_3_6_42_1","unstructured":"Australian Government Department of Health. The Australian immunisation program schedule (Current from 6 February 2023) [Internet]. [cited 7 Sep 2023]; https:\/\/www.health.gov.au\/sites\/default\/files\/2023-07\/national-immunisation-program-schedule.pdf"},{"key":"e_1_3_6_43_1","unstructured":"Ministry of Health of Brazil. Manual dos centros de refer\u00eancia para immunobiol\u00f3gicos especiais [Internet]. [cited 2023 Sep 7]; http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_centros_imunobiologicos_especiais_5ed.pdf"},{"key":"e_1_3_6_44_1","unstructured":"Minist\u00e8re de la Sant\u00e9 et de la Pr\u00e9vention. Calendrier des vaccinations et recommandations vaccinales [Internet]. [cited 2023 Sep 7]; https:\/\/sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal"},{"key":"e_1_3_6_45_1","unstructured":"Sant\u00e9 Publique France. Recommandations sanitaires pour les voyageurs 2019 [Internet]. [cited 2023 Sep 7]; https:\/\/www.santepubliquefrance.fr\/docs\/recommandations-sanitaires-pour-les-voyageurs-2019-a-l-attention-des-professionnels-de-sante"},{"key":"e_1_3_6_46_1","first-page":"333","article-title":"Recommendations of the standing committee on vaccination (STIKO) at the Robert Koch Institute","volume":"34","author":"STIKO","year":"2017","unstructured":"STIKO. Recommendations of the standing committee on vaccination (STIKO) at the Robert Koch Institute. Epidemilogisches Bulletin. 2017;34:333\u2013376.","journal-title":"Epidemilogisches Bulletin"},{"key":"e_1_3_6_47_1","unstructured":"North Atlantic Treaty Organization. Standards related document. AJMedP-4-7. Vaccinations catalogue within the NATO & PfP forces [Internet]. [cited 2023 Sep 7]; https:\/\/www.coemed.org\/files\/stanags\/02_AJMEDP\/AJMedP-4-7_SRD_EDA_V1_E_2561.pdf"},{"key":"e_1_3_6_48_1","unstructured":"Ireland National Immunisation Advisory Committee. Chapter 13. Meningococcal infection [Internet]. [cited 2023 Sep 7]; Available from: https:\/\/rcpi.access.preservica.com\/uncategorized\/IO_cf46ea72-2756-4e96-b22c-8e088ab7b9e4\/"},{"key":"e_1_3_6_49_1","unstructured":"Ireland National Immunisation Advisory Committee. Chapter 3. Immunisation of immunocompromised persons [Internet]. [cited 7 Sep 2023]; https:\/\/rcpi.access.preservica.com\/uncategorized\/IO_58401d43-5ce9-4aa0-858f-e5236cad3e27\/"},{"key":"e_1_3_6_50_1","unstructured":"Ireland National Immunisation Advisory Committee. Chapter 5. Immunisations and health information for travel [Internet] [cited 2023 Sep 7]; https:\/\/rcpi.access.preservica.com\/uncategorized\/IO_6f3f6a98-9086-458c-aedc-84e218487e15\/"},{"key":"e_1_3_6_51_1","unstructured":"State of Israel Ministry of Health Department of Epidemiology. National vaccination guidelines: prevention and control of meningococcal diseases [internet]. [cited 2023 Sep 7]; https:\/\/www.health.gov.il\/UnitsOffice\/HD\/PH\/epidemiology\/td\/docs\/320_MM.pdf"},{"key":"e_1_3_6_52_1","unstructured":"Ministry of Health of Italy. National vaccination plan 2017\u20132019 [Internet]. [cited 2023 Sep 7]; http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1264797"},{"key":"e_1_3_6_54_1","unstructured":"National Institute for Public Health and the Environment. Meningococcal disease in the Netherlands RIVM Report 2017-0031 [Internet]. [cited 2023 Sep 7]; https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2017-0031.pdf"},{"key":"e_1_3_6_55_1","unstructured":"New Zealand Ministry of Health. Immunisation handbook (2nd edition) [Internet]. [cited 2023 Sep 7]; Available from: https:\/\/www.health.govt.nz\/our-work\/immunisation-handbook-2020"},{"key":"e_1_3_6_56_1","unstructured":"New Zealand Immunisation Advisory Centre. Meningococcal disease [Internet]. [cited 2023 Sep 7]; https:\/\/www.immune.org.nz\/diseases\/meningococcal-disease"},{"key":"e_1_3_6_57_1","unstructured":"Portugal Ministry of Health. Programa nacional de vacina\u00e7\u00e3o [Internet] [cited 2023 Sep7]; https:\/\/www.sns.gov.pt\/noticias\/2020\/09\/30\/programa-nacional-de-vacinacao-2020\/"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpede.2021.11.002"},{"key":"e_1_3_6_59_1","unstructured":"General Directorate of Public Health Turkey. Hajj and Umrah vaccines [Internet]. [cited 2023 Sep 7]; https:\/\/asi.saglik.gov.tr\/asi-kimlere-yapilir\/liste\/31-hac-ve-umre-a%C5%9F%C4%B1lamalar%C4%B1.html"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00060-20"},{"key":"e_1_3_6_61_1","unstructured":"General Directorate of Public Health Turkey. Required vaccines and application schemes for healthcare professionals [Internet]. [cited 2023 Apr 13]. Available from: https:\/\/hsgm.saglik.gov.tr\/tr\/saglik-calisanlari-asilama.html"},{"key":"e_1_3_6_62_1","unstructured":"Medicana Health Group. Meningococcal vaccine [Internet]. [cited 2023 Apr 13]. Available from: https:\/\/www.medicana.com.tr\/saglik-rehberi-detay\/12474\/meningokok-asisi"},{"key":"e_1_3_6_63_1","unstructured":"National Health Service. MenACWY vaccine overview [Internet]. [cited 2023 Sep 7]; https:\/\/www.nhs.uk\/conditions\/vaccinations\/men-acwy-vaccine\/"},{"key":"e_1_3_6_64_1","volume-title":"The Green Book","author":"Public Health England","year":"2013","unstructured":"Public Health England. Chapter 12. Immunisation of Healthcare and Laboratory Staff. In: The Green Book. (UK); 2013."},{"key":"e_1_3_6_65_1","unstructured":"National Health Service. The routine immunisation schedule [Internet]. [cited 2023 Sep 7]; https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1055877\/UKHSA-12155-routine-complete-immunisation-schedule_Feb2022.pdf"},{"key":"e_1_3_6_66_1","unstructured":"National Health Service. Available vaccines: travel vaccinations [Internet]. [cited 2023 Sep 7]; https:\/\/www.nhs.uk\/conditions\/travel-vaccinations\/jabs\/"},{"key":"e_1_3_6_67_1","unstructured":"United Kingdom Royal Navy. Vaccinations [Internet]. [cited 2023 Sep 7]; https:\/\/www.royalnavy.mod.uk\/careers\/joining\/get-fit-to-join\/advice-and-guidance\/food-drink-and-lifestyle\/lifestyle\/vaccinations"},{"key":"e_1_3_6_68_1","unstructured":"The British Army. Vaccination in the armed forces \u2013 what you need to know [Internet]. [cited 2023 Sep 7]; https:\/\/www.army.mod.uk\/umbraco\/Surface\/Download\/Get\/4122"},{"key":"e_1_3_6_69_1","unstructured":"Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older [Internet]. [cited 2023 Sep 7]; https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/adult\/adult-combined-schedule.pdf"},{"key":"e_1_3_6_70_1","unstructured":"Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger: United States 2023 [Internet]. [cited 2023 Sep 7]; https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.5152\/tpa.2014.2206"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.5152\/ced.2015.1516"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030543"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep36996"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1979.03630430078026"},{"key":"e_1_3_6_77_1","unstructured":"Societa Italiana di Pediatria. Calendario vaccinale per la vita [Internet]. [cited 2023 Sep 7]; http:\/\/www.igienistionline.it\/docs\/2019\/21cvplv.pdf"},{"key":"e_1_3_6_78_1","unstructured":"Republica Italiana. Piano nazionale prevenzione vaccinale PNPV 2017\u20132019 [Internet]. [cited 2023 Sep 7]; https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf"},{"key":"e_1_3_6_79_1","unstructured":"New Zealand Immunisation Advisory Centre. Bexsero funded from 1 March 2023 [Internet]. [cited 2023 Sep 7]. Available from. https:\/\/www.immune.org.nz\/news\/bexsero-funded-from-1-march-2023"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpedi.2017.10.001"},{"key":"e_1_3_6_81_1","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary [Internet]. [cited 2022 Sep 7]. Available from: https:\/\/immunizationdata.who.int\/pages\/indicators-by-category\/planning_and_management.html?ISO_3_CODE=&YEAR="},{"key":"e_1_3_6_82_1","unstructured":"Ireland Health Service Executive. Going to Irish college? Are your vaccines up to date? [Internet]. [cited 2023 Sep 7]; https:\/\/www.hse.ie\/eng\/health\/immunisation\/news\/irishcollege%20.html"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2018.06.013"},{"key":"e_1_3_6_84_1","first-page":"437","article-title":"Meningococcal disease epidemiology and control in New Zealand","volume":"108","author":"Wilson N","year":"1995","unstructured":"Wilson N, Baker M, Martin D, et al. Meningococcal disease epidemiology and control in New Zealand. N Z Med J. 1995;108:437\u2013442.","journal-title":"N Z Med J"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1744979"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1071\/NB07047"},{"key":"e_1_3_6_87_1","unstructured":"Centre for Public Impact. New Zealand\u2019s meningococcal B immunisation programme [Internet]. [cited 2023 Sep 7]; https:\/\/www.centreforpublicimpact.org\/case-study\/meningococcal-b-immunisation-programme\/"},{"key":"e_1_3_6_88_1","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease [Internet]. [cited 2023 Sep 7]; https:\/\/www.cdc.gov\/meningococcal\/downloads\/17-275138A-MeningococcalDis-FS.pdf"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1809.120257"},{"key":"e_1_3_6_90_1","unstructured":"U.S. Department of Health & Human Services. Vaccines for military members [Internet]. [cited 2023 Sep 7]; https:\/\/www.vaccines.gov\/who_and_when\/military_members"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2102.141037"},{"key":"e_1_3_6_92_1","unstructured":"European Centre for Disease Prevention and Control. Rapid risk assessment: invasive meningococcal disease among men who have sex with men [Internet]. [cited 2023 Sep 7]; https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/rapid-risk-assessment-invasive-meningococcal-disease-among-MSM.pdf"},{"key":"e_1_3_6_93_1","unstructured":"New York City Department of Health and Hygiene. UPDATE: Invasive meningococcal disease in men who have sex with men four new cases reported in 2013 expanded vaccine recommendations [Internet]. [cited 2023 Sep 7]. Available from: https:\/\/cdn.hivguidelines.org\/wp-content\/uploads\/20160817171429\/alert-5-invasive-meningococcal-disease-in-msm-03-06-2013.pdf"},{"key":"e_1_3_6_94_1","unstructured":"State of Israel Ministry of Health. The Ministry of Health advises men who have sex with men who are planning to fly to New York to be vaccinated against meningitis (meningococcus) [Internet]. [cited 2023 Sep 7]; https:\/\/www.health.gov.il\/English\/News_and_Events\/Spokespersons_Messages\/Pages\/28042013_1.aspx"},{"key":"e_1_3_6_95_1","unstructured":"US Centers for Disease Control and Prevention. Meningococcal disease outbreak among gay bisexual men in Florida 2021\u20132023 [Internet]. [cited 2023 Sep 07]; https:\/\/www.cdc.gov\/meningococcal\/outbreaks\/FL2022.html"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.07.007"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.45.30392"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid0808.010422"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.05.022"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v6.i16.1128"},{"key":"e_1_3_6_101_1","unstructured":"Centers for Disease Control and Prevention. Saudi Arabia: Hajj & Umrah Pilgrimages. [cited 2023 Sep 7]; https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/itineraries\/saudi-arabia-hajj-and-umrah-pilgrimages"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz360.2403"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.068"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8573"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab917"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181817"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00754-4"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2015.01.013"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-80"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina54060100"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001553"},{"key":"e_1_3_6_112_1","unstructured":"World Health Organization. Global market study: meningococcal meningitis vaccines [Internet]. [cited 2023 Sep 7]; https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/mi4a\/who_meningococcal_vaccines_public_summary.pdf?sfvrsn=b3fb96f7_6&download=true"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.101"},{"key":"e_1_3_6_114_1","unstructured":"Brazilian Society of Immunization. Meningococcal B vaccines [Internet]. [cited 2023 Sep 7]. Available from: https:\/\/familia.sbim.org.br\/vacinas\/vacinas-disponiveis\/vacina-meningococica-b"},{"key":"e_1_3_6_115_1","unstructured":"Northern Territory Government. Immunisation schedule for children up to 19 years [Internet] [cited 2023 Sep 7]; https:\/\/digitallibrary.health.nt.gov.au\/prodjspui\/handle\/10137\/776"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.04.001"},{"key":"e_1_3_6_117_1","unstructured":"Government of Canada. Recommended immunization schedules: Canadian immunization guide [Internet]. [cited 2023 Sep 7]; https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-1-key-immunization-information\/page-13-recommended-immunization-schedules.html"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.01.003"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1682845"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1457595"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2020.1766265"},{"key":"e_1_3_6_122_1","unstructured":"World Health Organization. Defeating meningitis by 2030: a global road map [Internet]. [cited 2023 Sep 7]; https:\/\/www.who.int\/publications\/i\/item\/9789240026407"},{"key":"e_1_3_6_123_1","unstructured":"Pan American Health Organization World Health Organization. Meningococcus [Internet]. [cited 2023 Sep 7]; https:\/\/www.paho.org\/en\/topics\/meningococcus"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2023.2245467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:30:02Z","timestamp":1701883802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2023.2245467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/14760584.2023.2245467"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2023.2245467","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}